ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
3,855
Screening encounters
4,541
Diagnostic referrals
866
Outstanding pathways
311

Screening pathway

  1. Screening4,541Encounters
  2. Positive finding1,570Documented findings
  3. Referral866Diagnostic referrals
  4. Follow-up1,030Diagnostic visits
  5. Outcome555Resolved pathways

Stage totals use different units. Pending pathways: 311. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 0806 · EXP-0806Synthetic · Site B

Full participant history through 2026-11-22, across modalities and pathways.

  1. · Screening · VIA · Initial · Programme entry
  2. · Screening result · VIA · VIA positive · Adequate
  3. · Repeat plan · HPV DNA · Prior VIA positive · Scheduled for 2027-01-08
  4. · Diagnostic referral · EXP-0806-T-R
  5. · Contact attempt · Unsuccessful
  6. · Diagnostic booking · Initial booking
  7. · Contact attempt · Unsuccessful
  8. · Barrier documented · Contact difficulty
  9. · Contact attempt · Unsuccessful
  10. · Navigation intervention · Coordination support
  11. · Diagnostic visit · Attended
  12. · Diagnosis · Colposcopy · Biopsy collected
  13. · Diagnosis · Histopathology · No high-grade lesion identified
  14. · Surveillance plan · HPV DNA · After clinical assessment · Scheduled for 2027-09-04
  15. · Follow-up disposition · Resolved · EXP-0806-T-R

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Resolved

Screened participants

3855 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-1542 · Expanded synthetic participant 1542Site D — Community Engagement Programme
EXP-1543 · Expanded synthetic participant 1543Site E — Resource-Constrained Navigation Programme
EXP-1544 · Expanded synthetic participant 1544Site D — Community Engagement Programme
EXP-1545 · Expanded synthetic participant 1545Site E — Resource-Constrained Navigation Programme
EXP-1546 · Expanded synthetic participant 1546Site A — Urban Referral Hub
EXP-1548 · Expanded synthetic participant 1548Site C — Rural Outreach Programme
EXP-1549 · Expanded synthetic participant 1549Site E — Resource-Constrained Navigation Programme
EXP-1551 · Expanded synthetic participant 1551Site D — Community Engagement Programme
EXP-1552 · Expanded synthetic participant 1552Site A — Urban Referral Hub
EXP-1553 · Expanded synthetic participant 1553Site B — Peri-Urban Access Programme
EXP-1554 · Expanded synthetic participant 1554Site B — Peri-Urban Access Programme
EXP-1555 · Expanded synthetic participant 1555Site A — Urban Referral Hub
EXP-1557 · Expanded synthetic participant 1557Site A — Urban Referral Hub
EXP-1558 · Expanded synthetic participant 1558Site D — Community Engagement Programme
EXP-1559 · Expanded synthetic participant 1559Site B — Peri-Urban Access Programme
EXP-1560 · Expanded synthetic participant 1560Site D — Community Engagement Programme
EXP-1561 · Expanded synthetic participant 1561Site A — Urban Referral Hub
EXP-1562 · Expanded synthetic participant 1562Site A — Urban Referral Hub
EXP-1563 · Expanded synthetic participant 1563Site B — Peri-Urban Access Programme
EXP-1564 · Expanded synthetic participant 1564Site A — Urban Referral Hub
EXP-1566 · Expanded synthetic participant 1566Site B — Peri-Urban Access Programme
EXP-1567 · Expanded synthetic participant 1567Site E — Resource-Constrained Navigation Programme
EXP-1568 · Expanded synthetic participant 1568Site C — Rural Outreach Programme
EXP-1569 · Expanded synthetic participant 1569Site D — Community Engagement Programme
EXP-1570 · Expanded synthetic participant 1570Site B — Peri-Urban Access Programme

Programme insights

Encounters by modality

VIA
1736
HPV DNA
2166
Cytology
639

Navigation activity

Barrier documented
768
Contact attempt
1272
Navigation intervention
333
Diagnostic booking
1081
Diagnostic visit
1030

Documented barriers

Contact difficulty
247
Transport difficulty
253
Appointment coordination
268

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.